Retraction of: Extracellular vesicle derived miR-544 downregulates expression of tumor suppressor promyelocytic leukemia zinc finger resulting in increased peritoneal metastasis in gastric cancer
Wencheng Kong, Xinchun Liu, Guang Yin, Sixin Zheng, Akao Zhu, Panpan Yu, Yuqiang Shan, Rongchao Ying, Jian Zhang

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsExtracellular vesicles in disease · Retinoids in leukemia and cellular processes · Ferroptosis and cancer prognosis
This article has been retracted: Aging has completed its investigation of this paper. Several concerns were raised about the paper, including duplications and overlaps with unrelated papers from different institutions, as well as the reuse of previously published data. Specifically, the GAPDH Western blot image in Figure 1B is identical to the b-actin image in Figure 3D of an unrelated, earlier published paper [1]. Similarly, the PLZF blot in Figure 6B matches the USF1 blot in Figure 5A of the same paper [1]. Furthermore, immunofluorescence images from Figure 3D were previously published in Figure 5K of [2] and Figure 5B of [3]. Article [3] also shares a transwell assay image in Figure 5B with a panel in Figure 3D. Additionally, transwell assay images from Figure 3 appear in earlier published papers [4–12]. The transwell assay images from Figure 7 duplicate those found in articles [13–15], all of which have already been retracted. We also identified three later published articles that utilized some of the transwell images from Figures 3 and 7 [16, 17], and immunofluorescent images from Figure 3D [18]. The Scientific Integrity office at Aging contacted the authors regarding these issues. Dr. Wencheng Kong, the first author, requested a correction but did not follow up. In light of these findings, the Editors decided to retract the paper. The authors were informed of this decision and all authors agreed to retract the manuscript.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Guo J, Fang W, Chen X, Lin Y, Hu G, Wei J, Zhang X, Yang C, Li J. Upstream stimulating factor 1 suppresses autophagy and hepatic lipid droplet catabolism by activating m TOR. FEBS Lett. 2018; 592:2725–38. 10.1002/1873-3468.1320330054905 PMC 6175420 · doi ↗ · pubmed ↗
- 2Fang W, Guo J, Cao Y, Wang S, Pang C, Li M, Dou L, Man Y, Huang X, Shen T, Li J. Micro RNA-20a-5p contributes to hepatic glycogen synthesis through targeting p 63 to regulate p 53 and PTEN expression. J Cell Mol Med. 2016; 20:1467–80. 10.1111/jcmm.1283527019188 PMC 4956936 · doi ↗ · pubmed ↗
- 3Wang A, Zhang H, Wang J, Zhang S, Xu Z. Mi R-519d targets HER 3 and can be used as a potential serum biomarker for non-small cell lung cancer. Aging (Albany NY). 2020; 12:4866–78. 10.18632/aging.102908 Retraction in: Aging (Albany NY). 2025; 17:1581–2. DOI: 10.18632/aging.206265 PMID: 4063775132170048 PMC 7138586 · doi ↗ · pubmed ↗
- 4Jiang Z, Song Q, Zeng R, Li J, Li J, Lin X, Chen X, Zhang J, Zheng Y. Micro RNA-218 inhibits EMT, migration and invasion by targeting SFMBT 1 and DCUN 1D 1 in cervical cancer. Oncotarget. 2016; 7:45622–36. 10.18632/oncotarget.985027285984 PMC 5216747 · doi ↗ · pubmed ↗
- 5Li P, Wang H, Hou M, Li D, Bai H. Upstream stimulating factor 1 (USF 1) enhances the proliferation of glioblastoma stem cells mainly by activating the transcription of mucin 13 (MUC 13). Pharmazie. 2017; 72:98–102. 10.1691/ph.2017.678829441861 · doi ↗ · pubmed ↗
- 6Liu L, Yu D, Shi H, Li J, Meng L. Reduced lnc RNA Aim enhances the malignant invasion of triple-negative breast cancer cells mainly by activating Wnt/β-catenin/m TOR/PI 3K signaling. Pharmazie. 2017; 72:599–603. 10.1691/ph.2017.754729441885 · doi ↗ · pubmed ↗
- 7Zhou P, Li X. Serum mi R-338-5p has potential for use as a tumor marker for retinoblastoma. Oncol Lett. 2019; 18:307–13. 10.3892/ol.2019.10331 Retraction in: Oncol Lett. 2024; 27:215. DOI: 10.3892/ol.2024.14347 PMID: 3857206231289501 PMC 6540340 · doi ↗ · pubmed ↗
- 8Wang W, Yao S, Jiang H, Dong J, Cui X, Tian X, Guo Y, Zhang S. Upstream transcription factor 1 prompts malignancies of cervical cancer primarily by transcriptionally activating p 65 expression. Exp Ther Med. 2018; 16:4415–22. 10.3892/etm.2018.6758 Retraction in: Exp Ther Med. 2024; 28:342. DOI: 10.3892/etm.2024.12631 PMID: 3900645830542391 PMC 6257725 · doi ↗ · pubmed ↗
